AMETEK, Inc. vs KEYSIGHT TECHNOLOGIES, INC., two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where AME and KEYS diverge most: on debt / equity, AME reads 0.18 and KEYS reads 0.38; on revenue growth, AME reads +12.6% and KEYS reads +25.4%. The rest of the comparable metrics sit closer together. What AME's price implies is a bet that sits within the historical range (whole-company basis). What KEYS's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | AME | KEYS |
|---|---|---|
| Price | $248.36 | $382.75 |
| Market cap | $57.1B | $66.2B |
| Sector | Scientific Instruments | Scientific Instruments |
| Stage | Growth | Growth |
| P/E | 36.3 | 52.4 |
| P/B | 5.07 | 10.08 |
| P/S | 7.26 | 10.06 |
| EV/EBITDA | 23.9 | 41.1 |
| Revenue growth | +12.6% | +25.4% |
| Operating margin | 25.8% | 25.0% |
| Net margin | 20.0% | 19.1% |
| Return on equity | 14.0% | 19.2% |
| Return on assets | 9.5% | 10.6% |
| Return on invested capital | 12.7% | 12.2% |
| FCF yield | 3.2% | 2.2% |
| Dividend yield | 0.2% | — |
| Debt / equity | 0.18 | 0.38 |
| Current ratio | 1.21 | 2.02 |
| Altman Z (solvency) | 7.71 | 7.90 |
| Piotroski F (quality) | 8 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.